EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Function and Mechanism of OXCT1 in Tumor Progression as a Critical Ketone Body Metabolic Enzyme

Wen Qin iD, Wenwei Hu, Yiting Geng iD

Biomolecules · 19.12.2025 · 16 (1) · 4

DOI: 10.3390/biom16010004 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 19.12.2025. Verfasst von Wen Qin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, The Third Affiliated Hospital of Soochow University, 185 Juqian Street, Changzhou 213003, China. Hauptthemen laut MEDLINE: Coenzyme A-Transferases, Neoplasms, Ketone Bodies. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Changzhou "14th Five-Year Plan" High-level Health Personnel Training Project, Applied Basic Research Project of Changzhou Science and Technology Bureau, Jiangsu Provincial Administration of Traditional Chinese Medicine Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

3-Ketoacid CoA-transferase 1 (OXCT1) is a homodimeric mitochondrial matrix enzyme essential for ketone body metabolism. It catalyzes the reversible transfer of coenzyme A from succinyl-CoA to acetoacetate, playing a central role in extrahepatic ketone body catabolism. Accumulating evidence indicates that OXCT1 is dysregulated in various cancers, where it functions as an oncogene, driving tumor progression by modulating proliferation, metastasis, apoptosis, autophagy, and drug resistance. Its overexpression is associated with aggressive tumor behavior, metabolic adaptation, and poor clinical outcomes. This review systematically summarizes the molecular structure, biological functions, and regulatory mechanisms of OXCT1, highlighting its multifaceted roles in tumorigenesis and progression. Furthermore, we discuss its potential as a diagnostic biomarker, prognostic indicator, and therapeutic target, providing novel insights for developing OXCT1-based anticancer strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coenzyme A-TransferasesNeoplasmsKetone BodiesHumansAnimalsDisease ProgressionMetabolic Reprogramming

Stichwörter der Autor:innen

OXCT1drug resistanceketone body metabolismmetabolic reprogrammingtumor

Substanzen

Coenzyme A-Transferases3-ketoacid CoA-transferaseKetone Bodies

Autor:innen und Institutionen

  • Department of Oncology, The Third Affiliated Hospital of Soochow University, 185 Juqian Street, Changzhou 213003, China.
  • Jiangsu Engineering Research Center for Tumor Immunotherapy, The Third Affiliated Hospital of Soochow University, Changzhou 213003, China.

ORCID-Profile: Wen Qin, Yiting Geng

Förderung

  • Changzhou "14th Five-Year Plan" High-level Health Personnel Training Project
  • Applied Basic Research Project of Changzhou Science and Technology Bureau
  • Jiangsu Provincial Administration of Traditional Chinese Medicine Project
  • Changzhou “14th Five-Year Plan” High-level Health Personnel Training Project

Zitieren

APA

Qin, W., Hu, W., & Geng, Y. (2025). The Function and Mechanism of OXCT1 in Tumor Progression as a Critical Ketone Body Metabolic Enzyme. Biomolecules, 16(1), 4. https://doi.org/10.3390/biom16010004

Vancouver

Qin W, Hu W, Geng Y. The Function and Mechanism of OXCT1 in Tumor Progression as a Critical Ketone Body Metabolic Enzyme. Biomolecules. 2025;16(1):4. doi:10.3390/biom16010004

BibTeX
@article{Qin2025,
  author = {Qin, Wen and Hu, Wenwei and Geng, Yiting},
  title = {The Function and Mechanism of OXCT1 in Tumor Progression as a Critical Ketone Body Metabolic Enzyme},
  journal = {Biomolecules},
  year = {2025},
  volume = {16},
  number = {1},
  pages = {4},
  doi = {10.3390/biom16010004}
}
Kostenlos starten →